Danhong Injection Combined with Western Medicine Treatment of Respiratory Failure Clinical Experience

WANG Da-fang

doi:10.13422/j.cnki.syfjx.2015140177

您当前的位置：

首页 >

文章列表页 >

Danhong Injection Combined with Western Medicine Treatment of Respiratory Failure Clinical Experience

更新时间：2024-01-04

- Danhong Injection Combined with Western Medicine Treatment of Respiratory Failure Clinical Experience
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 21, Issue 14, Pages: 177-180(2015)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2015140177
  CLC： R563.8
- Published：2015
- 稿件说明：
移动端阅览
WANG Da-fang. Danhong Injection Combined with Western Medicine Treatment of Respiratory Failure Clinical Experience[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(14): 177-180.
DOI：

WANG Da-fang. Danhong Injection Combined with Western Medicine Treatment of Respiratory Failure Clinical Experience[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(14): 177-180. DOI： 10.13422/j.cnki.syfjx.2015140177.

摘要

目的: 探讨丹红注射液联合西药治疗呼吸衰竭临床疗效。方法: 对本院收治的80例呼吸衰竭患者资料进行分析

根据不同治疗方案将患者分为对照组和实验组各40例

对照组采用西药治疗

实验组在对照组治疗的基础上联合丹红注射液治疗

比较两组疗效及血浆黏度

血浆乳酸

动脉血氧分压(PaO2)

动脉血氧饱和度(SaO2)

动脉血二氧化碳分压(PaCO2)等指标。结果: 实验组95%患者疗效确切

高于对照组(85%)(P<0.05);实验组95%对治疗方案满意

高于对照组(65%)(P<0.01);实验组红细胞聚集指数为(1.35±0.10)

血浆黏度为(4.18±0.25)mPa ·s

红细胞比容为(0.41±0.07)

纤维蛋白原为(3.14±1.20) g ·L-1

低于对照组(P<0.05);实验组pH指标为(7.47±0.07)

PaO2指标为(75.77±8.32) mmHg

高于对照组(P<0.05);实验组PaCO2指标为(46.49±4.54) mmHg

低于对照组(P<0.05);实验组治疗后6 min步行距离为(372.5±57.3) m

长于对照组(P<0.05);实验组不良反应发生率为7.5%

显著低于对照组(不良反应发生率为17.5%)(P<0.05)。结论: 呼吸衰竭发病率较高

临床上采用丹红注射液联合西药治疗理想

值得推广使用。

Abstract

Objective: The aim of this study was to investigate the clinical effect of Danhong injection combined with western medicine treatment in patients with respiratory failure. Method: Eighty patients admitted to our hospital with respiratory failure were analyzed

according to the different treatment regimens

divided into control group and experiment group. The control group was given western medicine

while the experiment group was given Danhong injection combined with western medicine treatment

and the efficacy were compared. Result: In experiment group

the efficacy was 95%

higher than control group (85%) (P<0.05);95% patients of the experiment group were satisfied with the therapy

which was higher than control group (65%) (P<0.01);in experiment group erythrocyte aggregation index was (1.35±0.10)

plasma viscosity was (4.18±0.25) mPa · s

hematocrit was (0.41±0.07)

fibrinogen was (3.14±1.20) g · L-1

which were all lower than in the control group (P<0.05);in experiment group

pH indicators(7.47± 0.07) and PaO2 indicators (75.77±8.32) mmHg were both higher than the control group (P<0.05);in experiment group PaCO2 indicators (46.49±4.54) mmHg was lower than the control group (P<0.05);in the experiment group

6-min walking distance after treatment was (372.5±57.3) m

longer than in the control group (P<0.05). Conclusion: The respiratory failure has high incidence

and the use of Danhong injection combined with western medicine clinically should be introduced.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Efficacy-driving Mechanism of Danhong Injection for Stable Angina Pectoris Based on Composition-activity Relationship of Target Modules

Class-imbalance Prediction and High-dimensional Risk Factor Identification of Adverse Reactions of Traditional Chinese Medicine with Centralized Monitoring in Real-world Hospitals

Research Progress on Pharmacological Mechanism of Danhong Injection in Treatment of Cardiovascular and Cerebrovascular Diseases

Analysis of Modular Network Mechanism of Danhong Injection in Treatment of Coronary Angina Pectoris

Mechanism and Clinical Efficacy of Danhong Injection in Treatment of Coronary Heart Disease

Related Author

ZONG Wenjing

LIU Jun

YANG Wei

NIU Qikai

ZHANG Siqi

WANG Jing'ai

WANG Zhong

TIAN Siwei

Related Institution

Institute of Basic Theory for Chinese Medicine，China Academy of Chinese Medical Sciences

Institute of Basic Research in Clinical Medicine，China Academy of Chinese Medical Sciences

Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences， State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs， Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences

College of Art and Science，Boston University

College of Public Health and Health Professions，University of Florida

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰